2021 – Year in Review
2021 has been a progressive year for the MPCCC, despite the challenges of social isolation and rapidly changing circumstances for our healthcare [...]
New cancer treatment options for people in Gippsland
People being treated for cancer in Gippsland can now participate in clinical trials at Monash Health, opening up new therapeutic options that have not previously [...]
Monash Health to lead Australian first study of the response of COVID-19 vaccines on cancer patients
Monash Health researchers are working with collaborators across Australia on a new clinical trial that will investigate the response of COVID-19 vaccines in people with [...]
MRFF successes to boost Monash cancer research
Monash-based cancer researchers involved in collaborative research programs focused on children’s cancers, genomic risk profiling and cancer co-morbidities were beneficiaries of the latest Medical Research [...]
BroSupPORT: helping men living with prostate cancer to share and compare
The Prostate Cancer Outcomes Registry - Victoria (PCOR-Vic) at Monash University’s School of Public Health and Preventive Medicine, has been working with survivors of prostate [...]
Gippsland to gain better access to oncology clinical trials
Participating in life saving oncology clinical trials will soon become a more available option for cancer patients throughout Gippsland, following recommencement of the MPCCC’s Monash-Gippsland [...]
Embedding telehealth in cancer care after COVID-19
The uptake of telehealth by both patients and health professionals during COVID-19 presents a unique opportunity to reform the future care of people with cancer [...]
Our community’s views on research priorities for improving cancer care
This World Cancer Day, the MPCCC is celebrating the invaluable contribution of consumer and community involvement in supporting and prioritising cancer research. We asked our [...]
ENZAMET wins clinical trials award trifecta highlighting the importance of investigator-led research
Prostate cancer clinical trial ENZAMET has won a trifecta of prestigious awards at the 2020 Australian Clinical Trials Alliance (ACTA) Summit. In a first for [...]
MPCCC Precision Oncology Program reaches 100 patient milestone
Clinicians and patients across MPCCC partner health services have enthusiastically responded to the MPCCC Precision Oncology Program in 2020, and this month the program has reached [...]